NCT05100264

Brief Summary

Acidification of vaginal pH has been proposed as a potential factor that could help increase the efficacy of vaginal prostaglandins in labor induction. The aim of the present randomized controlled trial is to evaluate the impact of an acidic vaginal pH on the progress of labor induction with dinoprostone (Prostaglandin E2 - PGE2) vaginal tablet.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
230

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 29, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

October 29, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2022

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

1.2 years

First QC Date

October 18, 2021

Last Update Submit

February 19, 2024

Conditions

Keywords

labor inductiondinoprostonevaginal pH

Outcome Measures

Primary Outcomes (1)

  • Interval from induction to delivery

    Time interval (minutes)

    36 hours

Secondary Outcomes (3)

  • Interval from induction to active labor

    36 hours

  • Interval from induction to second stage of labor

    36 hours

  • Failure of induction of labor

    36 hours

Study Arms (2)

Vaginal washing 5% acetic acid

EXPERIMENTAL
Other: Vaginal washing with 5% acetic acid

Vaginal washing 0.9% N/S

PLACEBO COMPARATOR
Other: Vaginal washing with 0.9% NS

Interventions

Induction of labor (vaginal tablet dinoprostone and vaginal washing with 5% acetic acid)

Vaginal washing 5% acetic acid

Induction of labor (vaginal tablet dinoprostone and vaginal washing 0.9% NS)

Vaginal washing 0.9% N/S

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Singleton pregnancy
  • Full term (\>37 weeks)
  • Cephalic presentation
  • Reactive NST (nonstress test)
  • Absence of spontaneous uterine contractions
  • No contraindications to vaginal delivery

You may not qualify if:

  • Multifetal pregnancy
  • Fetal malpresentation
  • Preterm delivery (\<37 weeks)
  • Advanced maternal age (\>40 years)
  • Bishop score \> 7
  • Fetal macrosomia ( \>4500 gr)
  • Non reassuring NST (nonstress test)
  • Suspected chorioamnionitis
  • Previous cesarean delivery or other uterine surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alexandra General Hospital

Athens, 11528, Greece

Location

MeSH Terms

Interventions

Acetic Acid

Intervention Hierarchy (Ancestors)

AcetatesAcids, AcyclicCarboxylic AcidsOrganic ChemicalsFatty Acids, VolatileFatty AcidsLipids

Study Officials

  • Georgios Daskalakis

    Alexandra General Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Randomization will be computer generated. Allocation concealment will be ensured by opaque sealed envelopes. Blinding of outcomes assessor, principal as well as other investigators will be ensured as randomization will be performed by an external investigator that will not participate in the clinical process of the study or the statistical analysis. The ward midwife will open the randomization envelope after patient enrollment and different types of vaginal washing will be applied as per randomization. Participant as well outcomes assessor (physician that will evaluate the progress of labor as well statistician involved in the analysis) will be blinded to the procedure.
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Obstetrics and Gynecology

Study Record Dates

First Submitted

October 18, 2021

First Posted

October 29, 2021

Study Start

October 29, 2021

Primary Completion

December 29, 2022

Study Completion

December 30, 2022

Last Updated

February 20, 2024

Record last verified: 2024-02

Locations